We are live on
!
Find out more
CAM
Chou Associates Management Portfolio holdings
AUM
$210M
1-Year Est. Return
15.42%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+15.42%
3 Year Est. Return
+71.66%
5 Year Est. Return
+124.52%
10 Year Est. Return
+681.17%
AUM
$174M
AUM Growth
+$9.81M
(+6%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-8.03%
Top 10 Holdings %
Top 10 Hldgs %
93.88%
Holding
22
New
–
Increased
–
Reduced
4
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$6.81M |
| 2 |
Bank of America
BAC
|
+$2.1M |
| 3 |
DaVita
DVA
|
+$1.33M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$1.22M |
| 5 |
Bausch Health
BHC
|
+$780K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.2% |
| 2 | Healthcare | 32.82% |
| 3 | Technology | 1.96% |
| 4 | Industrials | 1.82% |
| 5 | Consumer Discretionary | 1.45% |
Similar funds
ESC
FSA
WI
UAH
UI
PCP
RWRC
GHP
Chou Associates Management's Q4 2019 Portfolio in Review
As of Q4 2019, Chou Associates Management held 22 positions worth $174M, up 6% from $164M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Chou Associates Management withdrew a net $13.9M in Q4 2019, closing 2 positions and reducing 4 holdings. Its most notable exit was Endo International plc, an estimated $1.22M position sold in full.
By sector, the portfolio is most concentrated in Financials at 49% of assets, down from 53% a quarter earlier, followed by Healthcare and Technology.
- Chou Associates Management's biggest Q4 2019 reduction was Wells Fargo, cutting an estimated $6.81M.
- Chou Associates Management fully exited Endo International plc in Q4 2019, selling an estimated $1.22M.
- Chou Associates Management's ten largest holdings make up 94% of its $174M portfolio in Q4 2019.
- Chou Associates Management opened 0 new positions and closed 2 in Q4 2019.
- Chou Associates Management's portfolio value rose 6% quarter-over-quarter to $174M.
Based on Chou Associates Management's 13F filing for Q4 2019, filed 4 Mar 2020.